Display options
Cite
Trojano M, Tintore M, Montalban X, et al. Treatment decisions in multiple sclerosis - insights from real-world observational studies. Nat Rev Neurol. 2017;13(2):105-118doi: 10.1038/nrneurol.2016.188.
Trojano, M., Tintore, M., Montalban, X., Hillert, J., Kalincik, T., Iaffaldano, P., Spelman, T., Sormani, M. P., & Butzkueven, H. (2017). Treatment decisions in multiple sclerosis - insights from real-world observational studies. Nature reviews. Neurology, 13(2), 105-118. https://doi.org/10.1038/nrneurol.2016.188
Trojano, Maria, et al. "Treatment decisions in multiple sclerosis - insights from real-world observational studies." Nature reviews. Neurology vol. 13,2 (2017): 105-118. doi: https://doi.org/10.1038/nrneurol.2016.188
Trojano M, Tintore M, Montalban X, Hillert J, Kalincik T, Iaffaldano P, Spelman T, Sormani MP, Butzkueven H. Treatment decisions in multiple sclerosis - insights from real-world observational studies. Nat Rev Neurol. 2017 Feb;13(2):105-118. doi: 10.1038/nrneurol.2016.188. Epub 2017 Jan 13. PMID: 28084327.
Copy Download .nbib Format: NLM
Share it on

Nat Rev Neurol. 2017 Feb;13(2):105-118. doi: 10.1038/nrneurol.2016.188. Epub 2017 Jan 13.

Treatment decisions in multiple sclerosis - insights from real-world observational studies.

Nature reviews. Neurology

Maria Trojano, Mar Tintore, Xavier Montalban, Jan Hillert, Tomas Kalincik, Pietro Iaffaldano, Tim Spelman, Maria Pia Sormani, Helmut Butzkueven

Affiliations

  1. Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza G. Cesare 11, 70124, Bari, Italy.
  2. Department of Neurology-Neuroimmunology and Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
  3. Department of Clinical Neuroscience, Karolinska Institutet, Tomtebodavägen 18A, S-17177, Solna, Stockholm, Sweden.
  4. Department of Medicine, University of Melbourne, and Department of Neurology, Royal Melbourne Hospital, Grattan Street, Parkville, VIC 3050, Australia.
  5. Department of Health Sciences (DISSAL), University of Genoa, Via Pastore 1, 16132, Genoa, Italy.

PMID: 28084327 DOI: 10.1038/nrneurol.2016.188

Abstract

The complexity of multiple sclerosis (MS) treatment means that doctors and decision-makers need the best available evidence to make the best decisions for patient care. Randomized controlled trials (RCTs) are accepted as the gold standard for assessing the efficacy and safety of any new drug, but conclusions of these trials do not always aid in daily decision-making processes. Indeed, RCTs are usually conducted in ideal conditions, so can measure efficacy only in restricted and unrepresentative populations. In the past decade, a growing number of MS databases and registries have started to produce long-term outcome data from large cohorts of patients with MS treated with disease-modifying therapies in real-world settings. Such observational studies are addressing issues that are otherwise difficult or impossible to study. In this Review, we focus on the most recently published observational studies designed to identify predictors of poor outcome and treatment response or failure, and to evaluate the relative and long-term effectiveness of currently used MS treatments. We also outline the statistical approaches that are most commonly used to reduce bias and limitations in these studies, and the challenges associated with the use of 'big MS data' to facilitate the implementation of personalized medicine in MS.

References

  1. Neurology. 2016 Feb 23;86(8):771-8 - PubMed
  2. Biometrics. 1998 Sep;54(3):948-63 - PubMed
  3. Neurology. 2006 Sep 26;67(6):944-53 - PubMed
  4. Brain. 2015 Nov;138(Pt 11):3287-98 - PubMed
  5. J Thorac Cardiovasc Surg. 2007 Nov;134(5):1128-35 - PubMed
  6. Control Clin Trials. 1990 Apr;11(2):101-15 - PubMed
  7. Ann Neurol. 2013 Jan;73(1):95-103 - PubMed
  8. Mult Scler. 2014 Oct;20(12):1602-8 - PubMed
  9. Ann Neurol. 2009 Oct;66(4):513-20 - PubMed
  10. Brain. 2015 Nov;138(Pt 11):3275-86 - PubMed
  11. Mult Scler. 2013 Apr;19(5):605-12 - PubMed
  12. Ann Neurol. 2004 Oct;56(4):548-55 - PubMed
  13. JAMA Neurol. 2014 Mar;71(3):269-70 - PubMed
  14. Cochrane Database Syst Rev. 2013 Jun 06;(6):CD008933 - PubMed
  15. Mult Scler. 2017 Feb;23 (2):234-241 - PubMed
  16. Ann Neurol. 2014 Jan;75(1):43-9 - PubMed
  17. Br J Surg. 2015 Jan;102(2):e93-e101 - PubMed
  18. Stat Med. 2012 Dec 30;31(30):4190-206 - PubMed
  19. Int J Epidemiol. 2010 Feb;39(1):89-94 - PubMed
  20. Mult Scler. 2016 Aug 1;:null - PubMed
  21. Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:69-80 - PubMed
  22. Mult Scler. 2006 Dec;12(6):769-74 - PubMed
  23. Lancet. 2012 Nov 24;380(9856):1829-39 - PubMed
  24. J Neurol. 2008 Apr;255(4):480-7 - PubMed
  25. Stat Med. 2016 May 10;35(10 ):1654-75 - PubMed
  26. Br J Clin Pharmacol. 2007 Feb;63(2):159-62 - PubMed
  27. Mult Scler. 2014 Oct;20(11):1523-32 - PubMed
  28. J Clin Epidemiol. 2009 May;62(5):464-75 - PubMed
  29. JAMA. 2012 Jul 18;308(3):247-56 - PubMed
  30. Mult Scler. 2016 Sep;22(10):1315-26 - PubMed
  31. Ann Neurol. 2016 Jun;79(6):950-8 - PubMed
  32. N Engl J Med. 2000 Jun 22;342(25):1887-92 - PubMed
  33. Neurol Clin Pract. 2016 Apr;6(2):102-115 - PubMed
  34. N Engl J Med. 2000 Sep 28;343(13):898-904 - PubMed
  35. Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):253-9 - PubMed
  36. Ann Clin Transl Neurol. 2015 Apr;2(4):373-87 - PubMed
  37. BMC Med Res Methodol. 2014 Jan 08;14:3 - PubMed
  38. Eur J Neurol. 2016 Apr;23 (4):729-36 - PubMed
  39. J Neurol. 2016 Aug;263(8):1626-32 - PubMed
  40. Mult Scler Relat Disord. 2015 Jul;4(4):329-33 - PubMed
  41. Stat Med. 2012 Aug 30;31(19):2098-109 - PubMed
  42. Acta Neurol Scand Suppl. 2012;(195):20-3 - PubMed
  43. J Clin Epidemiol. 2015 Apr;68(4):467-9 - PubMed
  44. Mult Scler. 2009 Jul;15(7):848-53 - PubMed
  45. Lancet. 2006 Oct 28;368(9546):1470-2 - PubMed
  46. Neurology. 2014 Apr 8;82(14):1204-11 - PubMed
  47. Health Econ. 2002 Jan;11(1):33-42 - PubMed
  48. Stat Med. 2004 Oct 15;23(19):2937-60 - PubMed
  49. Nat Rev Neurol. 2015 Mar;11(3):176-82 - PubMed
  50. Ann Neurol. 2006 Feb;59(2):344-52 - PubMed
  51. Int MS J. 2009 Sep;16(3):90-7 - PubMed
  52. Neurology. 2003 Dec 9;61(11):1528-32 - PubMed
  53. Lancet. 2001 May 19;357(9268):1576-82 - PubMed
  54. Neurology. 2016 Apr 5;86(14):1287-95 - PubMed
  55. Mult Scler. 2016 Nov;22(13):1732-1740 - PubMed
  56. Med Decis Making. 2009 Nov-Dec;29(6):661-77 - PubMed
  57. Acta Neurol Scand. 2012 Dec;126(6):390-7 - PubMed
  58. Lancet. 2005 Jan 1-7;365(9453):82-93 - PubMed
  59. N Engl J Med. 2000 Jun 22;342(25):1878-86 - PubMed
  60. BMC Neurol. 2015 Jun 18;15:93 - PubMed
  61. JAMA Neurol. 2015 Feb;72(2):152-8 - PubMed
  62. J Neurol. 2008 Feb;255(2):280-7 - PubMed
  63. Ann Neurol. 2016 Jul;80(1):89-100 - PubMed
  64. Nat Rev Neurol. 2016 Apr;12(4):217-33 - PubMed
  65. Ther Adv Neurol Disord. 2015 Jan;8(1):3-13 - PubMed
  66. J Am Med Inform Assoc. 2002 Nov-Dec;9(6):600-11 - PubMed
  67. Neurology. 2015 Apr 21;84(16):1639-43 - PubMed
  68. N Engl J Med. 2012 May 17;366(20):1870-80 - PubMed
  69. J Am Stat Assoc. 2013 Jan 1;108(502):527-539 - PubMed
  70. Brain. 2016 Sep;139(Pt 9):2395-405 - PubMed
  71. Mult Scler. 2008 May;14(4):479-84 - PubMed
  72. Mult Scler. 2017 Jan;23 (1):51-61 - PubMed
  73. Dialogues Clin Neurosci. 2011;13(2):217-24 - PubMed
  74. Lancet Neurol. 2009 Nov;8(11):987-97 - PubMed
  75. Lancet. 2009 Oct 31;374(9700):1503-11 - PubMed
  76. Ann Intern Med. 1991 Dec 1;115(11):901-5 - PubMed
  77. J Neurol. 2014 Jun;261(6):1170-7 - PubMed
  78. Am J Epidemiol. 2014 Jul 15;180(2):160-71 - PubMed
  79. Neurology. 2016 Jul 12;87(2):134-40 - PubMed
  80. Mult Scler. 2013 May;19(6):765-74 - PubMed
  81. Mult Scler. 2016 Nov;22(13):1642-1648 - PubMed
  82. Mult Scler. 2015 Aug;21(9):1159-71 - PubMed
  83. Arch Neurol. 2012 Feb;69(2):183-90 - PubMed
  84. J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):671-6 - PubMed
  85. J Am Med Inform Assoc. 2013 Jan 1;20(1):144-51 - PubMed
  86. Lancet Neurol. 2014 Oct;13(10):977-86 - PubMed
  87. Expert Rev Clin Pharmacol. 2014 May;7(3):293-8 - PubMed
  88. N Engl J Med. 2016 Feb 11;374(6):504-6 - PubMed
  89. JAMA. 2001 Sep 12;286(10):1187-94 - PubMed
  90. Epidemiology. 2009 Jul;20(4):512-22 - PubMed
  91. Mult Scler. 2016 Jan;22(1):85-93 - PubMed
  92. J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1190-7 - PubMed
  93. Neurology. 2011 May 31;76(22):1858-65 - PubMed
  94. Acta Neurol Scand. 2015;132(199):11-9 - PubMed
  95. Neurol Ther. 2016 Dec;5(2):193-201 - PubMed
  96. JAMA Neurol. 2014 Aug;71(8):954-60 - PubMed
  97. Mult Scler. 2017 Feb;23 (2):266-276 - PubMed
  98. Health Technol Assess. 2014 Jul;18(43):1-146 - PubMed
  99. Contemp Clin Trials. 2012 Nov;33(6):1211-6 - PubMed
  100. Intern Med J. 2017 Feb;47(2):144-157 - PubMed
  101. JAMA Neurol. 2013 Mar 1;70(3):338-44 - PubMed
  102. Lancet Neurol. 2011 Jun;10(6):520-9 - PubMed
  103. Nat Rev Neurol. 2015 Oct;11(10):597-606 - PubMed
  104. Mult Scler. 2014 Apr;20(5):566-76 - PubMed
  105. Ann Clin Transl Neurol. 2015 May;2(5):479-91 - PubMed
  106. JAMA Neurol. 2015 Apr;72(4):405-13 - PubMed
  107. Ann Neurol. 2015 Mar;77(3):425-35 - PubMed
  108. JAMA. 2001 Jan 24-31;285(4):430-6 - PubMed
  109. Stat Med. 2013 Aug 15;32(18):3158-80 - PubMed
  110. Neurology. 2014 Jan 21;82(3):248-54 - PubMed
  111. Neurol Sci. 2006 Sep;27 Suppl 5:S358-61 - PubMed
  112. Ann Intern Med. 2005 Feb 1;142(3):173-81 - PubMed
  113. Neurology. 2016 Apr 12;86(15):1446-53 - PubMed
  114. JAMA Neurol. 2014 Apr;71(4):436-41 - PubMed
  115. Brain. 2015 Jul;138(Pt 7):1863-74 - PubMed
  116. Eur J Neurol. 2015 Jul;22(7):1113-23 - PubMed
  117. Mult Scler. 2016 Sep;22(10):1297-305 - PubMed
  118. Reprod Health. 2015;12 Suppl 2:S2 - PubMed
  119. Lancet Neurol. 2015 May;14 (5):497-505 - PubMed
  120. Acta Neurol Scand. 2015;132(199):4-10 - PubMed
  121. N Engl J Med. 2016 Jun 2;374(22):2152-8 - PubMed

MeSH terms

Publication Types